- Home
- BEEM vs ANTX Comparison
BEEM vs ANTX Comparison
Compare BEEM & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- ANTX
- Stock Information
- Founded
- BEEM 2006
- ANTX 2017
- Country
- BEEM United States
- ANTX United States
- Employees
- BEEM N/A
- ANTX N/A
- Industry
- BEEM Semiconductors
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- ANTX Health Care
- Exchange
- BEEM Nasdaq
- ANTX Nasdaq
- Market Cap
- BEEM 35.5M
- ANTX 33.2M
- IPO Year
- BEEM N/A
- ANTX 2022
- Fundamental
- Price
- BEEM $2.32
- ANTX $1.06
- Analyst Decision
- BEEM Strong Buy
- ANTX Buy
- Analyst Count
- BEEM 4
- ANTX 2
- Target Price
- BEEM $5.33
- ANTX $2.00
- AVG Volume (30 Days)
- BEEM 682.4K
- ANTX 76.3K
- Earning Date
- BEEM 08-12-2025
- ANTX 08-12-2025
- Dividend Yield
- BEEM N/A
- ANTX N/A
- EPS Growth
- BEEM N/A
- ANTX N/A
- EPS
- BEEM N/A
- ANTX N/A
- Revenue
- BEEM $41,099,000.00
- ANTX N/A
- Revenue This Year
- BEEM N/A
- ANTX N/A
- Revenue Next Year
- BEEM $38.51
- ANTX N/A
- P/E Ratio
- BEEM N/A
- ANTX N/A
- Revenue Growth
- BEEM N/A
- ANTX N/A
- 52 Week Low
- BEEM $1.33
- ANTX $0.87
- 52 Week High
- BEEM $6.25
- ANTX $2.70
- Technical
- Relative Strength Index (RSI)
- BEEM 53.45
- ANTX 43.83
- Support Level
- BEEM $2.18
- ANTX $1.05
- Resistance Level
- BEEM $2.74
- ANTX $1.09
- Average True Range (ATR)
- BEEM 0.33
- ANTX 0.03
- MACD
- BEEM -0.05
- ANTX -0.00
- Stochastic Oscillator
- BEEM 32.50
- ANTX 9.43
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.